Navigation Links
Phytomedics Inc. To Present at BIO 2010 International Convention
Date:4/28/2010

JAMESBURG, N.J., April 28 /PRNewswire/ -- Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of drugs and consumer products solely derived from plant sources, today announced that Dr. Laurie Smaldone, MD, President and Chief Executive Officer, will deliver a corporate presentation at the BIO 2010 International Convention on Thursday, May 6th, at McCormick Place Convention Center in Chicago.

Dr. Smaldone's presentation will take place at 9:30 a.m. CDT in Presentation Room D, as part of the 2010 BIO Business Forum.

Her presentation will provide a corporate overview and highlight the clinical progress of the company's lead drug candidate, PMI-001, a novel, oral, disease-modifying, non-steroidal, natural product alternative to injectable biologicals in patients with RA.

Three U.S. based, FDA-approved clinical trials, have confirmed biological like efficacy of this botanical drug candidate as a stand-alone therapy in reducing signs and symptoms of RA at all American College of Rheumatology (ACR) endpoints,  a rapid onset of action and, the ability to halt joint erosions and narrowing with an acceptable side effect profile.  Combined with the fact that this natural botanical drug product is delivered as an oral dosage form, and has no steroid like side effects, makes PMI-001 truly is a game changing therapeutic opportunity in RA, as well as in the wider AA space.

About Phytomedics Inc.

Phytomedics, Inc. is a clinical stage biopharmaceutical company with a novel portfolio of drugs and consumer products solely derived from plant sources. Through this proprietary te
'/>"/>

SOURCE Phytomedics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014   Assurex Health, a ... to healthcare providers for behavioral health and chronic ... $30 million in equity financing from new and ... , President and Chief Executive Officer. ... development of Assurex Health,s GeneSight ® ...
(Date:12/24/2014)... 23, 2014 Tianyin Pharmaceutical Co., Inc. ... in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... announced that the Company achieved the Public Notice ... (GMP) certificate of TPI,s Qionglai Facility (QLF) from ... public notice period is a significant procedure of ...
(Date:12/24/2014)... Dec. 23, 2014  Medical Science Liaisons play a ... link between the medical device industry and key stakeholders, ... the coming years as the device industry relies on ... to research by benchmarking firm, Best Practices, LLC, one ... important edge is by harnessing new technology to enable ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... Trial Raise Questions for,Patients, OAK BROOK, Ill., ... Trial, published in the September 18 issue of ... the technology,s,ability to diagnose intermediate- to large-sized polyps ... not as effective in diagnosing small polyps. CT,colonography ...
... Study Results Published in the September 18th New England ... die from colorectal cancer. Many,of these deaths could be ... 50 and older who should be screened for the ... cost, inconvenience, and safety,concerns associated with current screening exams., ...
Cached Medicine Technology:ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy 2
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the Best ... 2014. The awards program, created in 2000, is one ... the country. The program is a public/private partnership between ... Economic Development, the Pennsylvania State Council of the Society ... Journal. , Charlie Wilson, Vice President of ...
(Date:12/26/2014)... Parker & Sons, Inc. a reliable ... cooling and plumbing contractor services throughout Arizona announces ... 2014 with regard to air-conditioning systems. Residential and ... for its incredibly hot summers. Working with an ... details of a wide variety of systems made ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Product liability ... ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move ... to an Order issued in the U.S. District Court, ... will convene an open conference on January 7, 2015, ... States Courthouse in West Palm Beach, Florida. The Conference ...
Breaking Medicine News(10 mins):Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3
... & Lomb, the global eye health company, has entered ... for the development of certain intraocular lens (IOL) materials. ... has obtained the rights to Santen,s hydrophobic acrylic polymers, ... worldwide. Santen reserves the right for the use of ...
... March 3 Marinus Pharmaceuticals, Inc. today announced that ... clinical trial investigating the safety and efficacy of ganaxolone ... a type of epilepsy. In this trial, ganaxolone ... Efficacy was seen in the first week of ...
... supplies has unveiled their annual 2009 list of what to do if ... ... Nationwide Medical/Surgical , a distributor of the flu vaccine and flu ... if exposed to the flu virus., , ,The flu is a highly ...
... Study finds it alters levels of hormones, could raise risk ... 2 -- Working the night shift might lead to hormonal ... heart disease, researchers say. , "In the long run, the ... the regulation of body weight -- leptin, insulin, cortisol -- ...
... KIRKLAND, Wash., Feb 26 ProteoTech Inc. announced ... from The Michael J. Fox Foundation for Parkinson,s ... (Philadelphia, PA), ProteoTech scientists will utilize ProteoTech,s small ... agents that will allow doctors to use PET ...
... 2 Speaker Nancy Pelosi released the following ... Sebelius as Secretary of the Department of Health and ... leader who has worked to expand health care access ... drugs. "Governor Sebelius, deep understanding of health care issues ...
Cached Medicine News:Health News:Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development 2Health News:Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures 2Health News:Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures 3Health News:Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures 4Health News:Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus 2Health News:Night Shift Work Hard on the Heart 2Health News:Night Shift Work Hard on the Heart 3Health News:ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinson's Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinson's Brain 2
Integrated electronics, three-chip CCD camera with PAL and NTSC output at 750 lines, RGB-video. 44mm x 49mm x 75mm, 180 grams....
Large image and wide-angle design....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
PDA application listing specific ICD-9 coding listed in new Medicare National Coverage Determinations....
Medicine Products: